Poulton Jeffrey V. (CIK 0001782962)

Latest company ownership

ALNY - ALNYLAM PHARMACEUTICALS, INC.

Role: CFO

Shares held

57

Last filed at

Oct 3, 2025

Confidence Score

92.4

2025Q4

Confidence Score History

2021Q2 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Oct 1, 2025	Oct 3, 2025	ALNYLAM PHARMACEUTICALS, INC.	CFO	Sell	95.0	+3,931	7.83%	✗	$1.7M
Aug 15, 2025	Aug 19, 2025	ALNYLAM PHARMACEUTICALS, INC.	CFO	Sell	92.5	+2,370	4.96%	✗	$1M
Mar 3, 2025	Mar 5, 2025	ALNYLAM PHARMACEUTICALS, INC.	CFO	Sell	97.5	+13,853	40.80%	✗	$308.1K
Feb 27, 2025	Mar 3, 2025	ALNYLAM PHARMACEUTICALS, INC.	CFO	Sell	42.5	-796	-2.29%	✗	$192.4K
Feb 13, 2025	Feb 18, 2025	ALNYLAM PHARMACEUTICALS, INC.	CFO	Sell	90.0	+2,142	6.98%	✗	$246.7K
Nov 25, 2024	Nov 27, 2024	ALNYLAM PHARMACEUTICALS, INC.	CFO	Sell	92.5	+1,752	6.05%	✗	$422.1K
Jun 24, 2024	Jun 26, 2024	ALNYLAM PHARMACEUTICALS, INC.	CFO	Sell	92.5	+1,673	6.13%	✗	$370.7K
Feb 27, 2024	Feb 29, 2024	ALNYLAM PHARMACEUTICALS, INC.	CFO	Sell	42.5	-574	-2.85%	✗	$89.1K
Feb 15, 2024	Feb 20, 2024	ALNYLAM PHARMACEUTICALS, INC.	CFO	Sell	95.0	+2,271	14.26%	✗	$149.1K
Aug 3, 2023	Aug 7, 2023	ALNYLAM PHARMACEUTICALS, INC.	CFO	Sell	97.5	+4,167	35.42%	✗	$643K
Apr 26, 2023	Apr 28, 2023	ALNYLAM PHARMACEUTICALS, INC.	CFO	Sell	95.0	+2,300	24.31%	✗	$190.1K
Aug 3, 2022	Aug 5, 2022	ALNYLAM PHARMACEUTICALS, INC.	CFO	Sell	97.5	+6,271	196.46%	✗	$968.8K
Apr 19, 2021	Apr 21, 2021	ALNYLAM PHARMACEUTICALS, INC.	CFO	Sell	95.0	+3,173	100.00%	✗	$182.3K